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1. Introduction 
Glucocorticoids can readily diffuse into the cells due to their lipophilic nature and bind to 
glucocorticoid (GR) and mineralocorticoid (MR) receptors, which, in the inactive form, are 
associated with other proteins in the cytosol. MR was shown to bind most of the 
glucocorticoids under basal conditions. However, after an increase in the circulating levels 
of glucocorticoids (i.e. caused by exposure to stress or during the circadian and ultradian 
peaks of glucocorticoid secretion) GRs are predominantly activated (de Kloet et al., 2005). 
The activated receptor undergoes conformational changes followed by the translocation of 
the ligand-bound complex to the nucleus. Within this subcellular compartment, this 
complex can form homo or heterodimers and bind to responsive elements (GREs) in the 
promoter region of target genes, a mechanism known as transactivation, or interact with 
transcription factors as monomers to modulate the transcription of responsive genes, a 
mechanism known as transrepression. The main transcriptional factors involved in these 
responses are the nuclear factor kappa B (NFB) and the AP-1 protein family. 
More recently, it has been suggested that nontranscriptional actions may account for the 
very rapid effects observed with acute glucocorticoid treatment (Limbourg & Liao, 2003). 
These actions differ from the classic genomic responses by the targets, type of interaction 
and period of action, being detected within few minutes after hormone secretion (Mikics et 
al., 2004; Sandi et al., 1996). The administration of high doses of dexamethasone was shown 
to protect the myocardial tissue from infarction and stroke through the prompt activation of 
endothelial nitric oxide (NO) system (Hafezi-Moghadam et al., 2002). During the 1990’s, NO 
has been identified as a potent vasodilatatory gas. Its properties in decreasing blood 
pressure are still clinically explored by the use of NO donors as anti-hypertensive drugs. 
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More recently, NO has also been implicated in neuromodulation, exerting its actions in an 
autocrine or paracrine manner in the central nervous system (CNS). 
In general, these rapid effects mediated by glucocorticoids seem to modulate signaling 
(through actions on ion channels, neuromodulators, neurotransmitters and other receptors 
systems), being very distinctive depending on the brain areas involved. It is generally 
accepted that glucocorticoids increase the excitability in some areas, like hippocampus and 
amygdala, and potentially decrease neuronal activity in others, such as the hypothalamus. 
Since the expression of glucocorticoid receptors vary considerably in the CNS, 
glucocorticoids are likely to modulate not only the activity of the hypothalamic-pituitary-
adrenal (HPA) axis, but also indirectly modify the inputs to hypothalamic neurons, 
projecting from the limbic system and cerebral cortex. 
The classic glucocorticoid receptors GR and MR have already been identified in neuronal 
and non-neuronal cellular membranes, although their involvement in these nongenomic 
responses is still controversial (Gametchu et al., 1993; Lipositis & Bohn, 1993). In pituitary-
derived cells, the use of a GR antagonist prevented the dexamethasone-induced 
translocation of annexin-1, which was implicated in the rapid inhibition of 
adrenocorticotrophic hormone (ACTH) release (Buckingham et al., 2003; Solito et al., 2003; 
Tierney et al., 2003). Nevertheless, a GR-independent pathway has been also reported in the 
fast feedback mechanism at the pituitary level in vivo (Hinz & Hirschelmann, 2000). 
Another line of evidence suggests that most of nongenomic responses are mediated by the 
glucocorticoid binding to G-coupled protein receptors (Liu & Chen, 1995; Orchinik et al., 
1991). In tumor-derived cells, a receptor coupled to an inhibitory G-protein (Gi) has been 
implicated in the glucocorticoid-induced inhibition of ACTH release (Iwasaki et al., 1997). In 
the hypothalamus, however, the production and release of neuromodulators 
(endocannabinoids and NO) seem to be driven by the activation of a membrane receptor 
associated with a stimulatory G-protein (Gs) (Di et al., 2009). Endocannabinoids were shown 
to mediate most of the nongenomic actions of the glucocorticoids, including the rapid 
negative feedback on the HPA axis (Evanson et al., 2010). Accordingly, several signaling 
pathways have been implicated in the responses induced by glucocorticoids downstream 
from the putative membrane receptors, mainly including protein kinase A (PKA)- and 
protein kinase C (PKC)-derived mechanisms (Han et al., 2002, 2005; Lou & Chen, 1998; Qiu 
et al, 1998, 2003). 
2. Glucocorticoids and energy balance 
2.1. The control of food intake by glucocorticoids: novel aspects 
The motivated behaviour of eating comprises one of the most primordial responses in all 
species. It is regulated by several factors, including adiposity (leptin and insulin) and satiety 
signals (such as mechanical and chemical stimulation of stomach and small intestine), as 
well as hormones [such as cholecystokinin (CCK)] (Schwartz et al., 2000). The adiposity 
factors are involved in the long-term control of energy balance and act primarily in 
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hypothalamic neurons expressing orexigenic or anorexigenic neuropeptides (Schwartz et al., 
2000). Neuropeptide Y (NPY) and agouti related protein (AgRP) in the arcuate nucleus of 
the hypothalamus (ARC), and orexins and melanin-concentrating hormone (MCH) in the 
lateral hypothalamic area (LHA), represent the main hypothalamic orexigenic 
neuropeptides (Gehlert, 1999; Smith & Ferguson, 2008; Valassi et al., 2008). In contrast, 
proopiomelanocortin (POMC) and cocaine and amphetamine-regulated transcript (CART) 
in the ARC, and corticotrophin-releasing factor (CRF) and oxytocin (OT) in the 
paraventricular nucleus of the hypothalamus (PVN) are the main mediators involved in the 
inhibition of food intake (Schwartz et al., 2000; Valassi et al., 2008). The localization of the 
above mentioned neuropeptides in hypothalamic nuclei is summarized in Table 1. The 
satiety signals, in turn, are implicated in the short-term control of food intake and have their 
actions mediated by brainstem areas, primarily by the nucleus of the solitary tract (NTS), 
which is implicated in the control of meal size (Havel, 2001). It is well established that the 
hypothalamic nuclei involved in the control of food intake have reciprocal connections with 
the brainstem (Sawchenko & Swanson, 1982; Swanson & Kuypers, 1980). This evidence 
provides the neuroanatomical basis for the hypothesis that adiposity signals may modulate 
satiety (Matson & Ritter, 1999; Wang et al., 2000).   
 
Neuropeptides Localization in the hypothalamus 
NPY ARC 
AgRP ARC 
Orexins LHA and PFA 
MCH LHA 
POMC ARC 
CART ARC, PVN and SON 
CRF PVN 
OT PVN and SON 
Table 1. Hypothalamic localization of the neuropeptides involved in the control of food intake. NPY, 
neuropeptide Y; ARC, arcuate nucleus of the hypothalamus; AgRP, agouti related protein; LHA, lateral 
hypothalamic area; PFA, perifornical area; MCH, melanin-concentrating hormone; POMC, 
proopiomelanocortin; CART,  cocaine and amphetamine-regulated transcript; PVN, paraventricular 
nucleus of the hypothalamus; SON, supraoptic nucleus of the hypothalamus; CRF, corticotrophin-
releasing factor; OT, oxytocin. 
Glucocorticoids play an important role in the control of energy balance (La Fleur, 2006). It is 
well established that a peak in the concentration of glucocorticoids occurs immediately 
before or at the onset of the activity period, with a progressive decrease in the HPA axis 
activity being detected over the remaining period within 24 hours, resulting in the classic 
circadian rhythm (Moreira & Leal, 1997). In addition, this rhythm occurs due to 
glucocorticoids release from the adrenal gland in discrete pulses, which results in an 
ultradian rhythm. Changes in the amplitude of these pulses, and to a lesser extent in their 
frequency, determine the pattern of the circadian rhythm (Lightman et al., 2008). In fact, it 
has been also demonstrated that feeding is a major synchronizer of the HPA axis 
rhythmicity (Leal & Moreira, 1997), being the size of the meal directly related to 
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glucocorticoid secretion (Honma et al., 1983). At the same time, increased food intake and 
body weight gain have been observed in humans following glucocorticoid treatment 
(Tataranni et al., 1996). Stress conditions, characterized by elevated circulating 
glucocorticoids levels, are also associated with increased food intake, body weight gain and 
obesity (Dallman et al., 2003; La Fleur, 2006; Spencer & Tilbrook, 2011).  
Consistent with the importance of glucocorticoids on energy homeostasis are two very 
prevalent clinical conditions: 1) Cushing’s syndrome, which is characterized by clinical 
findings that include abnormalities in the HPA axis rhythmicity, insulin resistance and 
hyperglycaemia secondary to hypercortisolism. The most common cause of Cushing’s 
syndrome is the administration of pharmacological doses of oral, parenteral and, rarely, by 
topical glucocorticoids. Endogenous glucocorticoid excess may arise from ACTH–secreting 
pituitary tumors, ectopic (nonpituitary) ACTH production, or adrenal tumors. 
Hypercortisolaemia is associated with increased glucose production, decreased glucose 
transport and utilization, decreased protein synthesis, increased protein degradation in 
muscle and body weight gain (Nieuwenhuizen & Rutters, 2008; Shibli-Rahhal et al., 2006); 
(2) Addison’s disease or primary adrenal insufficiency, first described by Addison in 1855, is 
characterized by an inability of the adrenal cortex to synthesize and secrete glucocorticoids 
and mineralocorticoids. Chronically, the main clinical findings observed in patients with 
Addison’s disease include malaise, fatigue, anorexia, weight loss, darkening of the skin, 
hyponatraemia, hypoglycaemia and hyperkalaemia (Nieman and Chanco Turner, 2006). 
It has been shown that the effects of glucocorticoids on food intake can vary according to 
their concentration in the circulation (Devenport et al., 1989).  Low doses of corticosterone 
administered to adrenalectomized (ADX) rats activate MR and induce a stimulatory effect 
on fat intake, body weight gain and fat depot, being these effects prevalent at the late phase 
of the feeding period, the same period in which HPA axis activity is reduced during the 
circadian variation  (Tempel & Leibowitz, 1994, 1989; Tempel et al., 1991). In contrast, GRs 
are activated by higher doses of circulating corticosterone, being this effect observed just 
before or at the first hours after the beginning of the feeding period, mimicking the peak of 
glucocorticoids secretion within the 24 hours of circadian rhythm. Such high levels of 
circulating glucocorticoids produce an increase in carbohydrate ingestion and metabolism 
(Goldstein et al., 1993; Kumar & Leibowitz, 1988; Kumar et al., 1988; Tempel & Leibowitz, 
1994, 1989; Tempel et al., 1993). In addition, extremely high corticosterone plasma 
concentrations, such as those observed in response to stress or food restriction, stimulate fat 
and protein catabolism (mainly from muscular source) and, consequently, body weight loss, 
which increases the availability of gluconeogenesis substrates and enhances glucose plasma 
concentrations (Tempel & Leibowitz, 1994; Tomas et al., 1979).  
Historically, the brain has been considered the main regulator of hunger and satiety. 
However, the existence of a unique hypothalamic satiety or hunger center, as proposed a 
few decades ago, is no longer acceptable. It has been demonstrated that dexamethasone 
injection into the lateral ventricle not only stimulates food intake but also enhances body 
weight gain in rats, being these effects accompanied by hyperleptinaemia and 
hyperinsulinaemia (Cusin et al., 2001; Zakrzewska et al., 1999).  These central effects of 
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glucocorticoids seem to be mediated by their interaction with neurons co-expressing 
glucocorticoid receptors and neuropeptides involved in the control of energy homeostasis 
(Aronsson et al., 1988; Hisano et al., 1988). This hypothesis has been evaluated by Zakrzewska 
and co-workers (1999), who demonstrated that the hypothalamic levels of NPY and CRF were, 
respectively, increased and decreased in response to the intracerebroventricular 
administration of dexamethasone. In addition, circulating glucocorticoids were shown to be 
required for the feeding-induced decrease in the expression of orexigenic neuropeptides in the 
ARC, as well as for the increased expression of the anorexigenic neuropeptide POMC in the 
same nucleus (Uchoa et al., 2012). It has been hypothesized by these authors that these effects 
would occur either by a direct effect of glucocorticoids on ARC neurons or indirectly by the 
feeding-induced secretion of leptin and insulin.  
The removal of endogenous glucocorticoids induced by bilateral ADX surgery is one of the 
most used experimental models for replicating the human Addison’s disease. The food 
intake and body weight gain are reduced in ADX animals, being these effects reversed by 
glucocorticoid replacement (Freedman et al., 1985; Uchoa et al., 2009a, 2009b, 2010). 
Furthermore, ADX is effective in diminishing hyperphagia and obesity under diverse 
experimental conditions (Bruce et al., 1982; Dubuc and Wilden, 1986; Yukimura et al., 1978). 
The ADX-induced hypophagia has been associated with a decrease of hypothalamic NPY 
and AgRP mRNA expression (Strack et al., 1995; Uchoa et al., 2012). Conversely, ADX 
induces an increase in the expression of CRF and OT in PVN (Uchoa et al., 2009b and 2010). 
The actions on these two peptides in the control of food intake were confirmed by the 
central administration of OT and CRF-2 receptor antagonists, which were able to reverse the 
ADX-induced hypophagic effect (Uchoa et al., 2009b and 2010). 
It has been hypothesized that the stimulatory action of glucocorticoids on food intake may 
involve an increased drive for eating. Accordingly, it is believed that the ADX-induced 
hypophagia is caused, at least in part, by a reduction of this motivated behaviour. However, 
there are few evidences concerning the role of glucocorticoids on the satiety-related 
responses. Recent studies have demonstrated that the hypophagic response induced by 
ADX is associated with increased activation of satiety-related responses mediated by 
brainstem and hypothalamic circuits (Uchoa et al., 2009a, 2009b). Accordingly, the activation 
of NTS neurons, assessed by the increased number of cells expressing the nuclear c-Fos 
protein, is increased in ADX animals after feeding, indicating that this nucleus may be 
involved in the increased satiety responses following glucocorticoid deficiency (Uchoa et al., 
2009a). Interestingly, the activation of CRF and OT neurons was also enhanced in the PVN 
of fed ADX rats, indicating that, besides the brainstem, the hypothalamus may be also 
involved in these satiety-related responses. Furthermore, this increased activation of satiety-
related responses in the NTS following ADX is reversed by CRF2 receptor antagonist, 
indicating that CRF also plays an important functional neuromodulatory role in the 
brainstem (Uchoa et al., 2010). 
In addition to the reduced drive to eat and the increased satiety observed in ADX animals, a 
change in both the concentration as well as in the sensitivity to peripheral factors seems to 
underlie the hypophagic effect of glucocorticoid deficiency. Accordingly, ADX reduces 
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plasma leptin levels in ad libitum rats (Germano et al., 2007; Savontaus et al., 2002), as well as 
the meal-induced insulin secretion (Germano et al., 2008; Uchoa et al., 2012), whereas 
glucocorticoid treatment increases leptin secretion and leptin expression in adipocytes 
(Jahng et al., 2008; Slieker et al., 1996; Zakrzewska et al., 1999). Furthermore, the sensitivity 
to insulin and leptin seems to be enhanced after ADX (Chavez et al., 1997; Zakrzewska et al., 
1997), although CCK administration did not significantly alter food intake in ADX rats 
(Uchoa et al, 2009a). Another hormone that arises as a candidate for the modulation by 
glucocorticoids is ghrelin, although the effects of this hormone on food intake may also be 
produced independently of glucocorticoid action.  
The physiological instinct of obtaining energy through food intake is parallel to the equally 
important development of satiation signals, which may terminate the ingestive behaviour as 
soon as the organism is replenished. Glucocorticoids have a well established role in both 
processes, contributing to the enhanced drive to eat as well as to the reduction of satiety-
related responses. However, it is believed that, particularly in humans, the initiation of a 
meal often starts in the absence of any depletion signal, which means that it is possible for 
other brain areas such as the cortex and the limbic system to overcome the inputs coming 
from the hypothalamus and the brainstem, turning the organism into an ingestive mode, 
which actually exceeds its needs. Accordingly, both real and potential challenges that 
activate the HPA axis and, consequently, alter the secretion of glucocorticoids, may also 
disrupt this balance. 
2.2. Glucocorticoids in the interface of immune challenges and food intake 
Under acute immune challenges, the body produces a strong inflammatory response to the 
pathogens. This generalized reaction, triggered by the organism in order to safeguard the 
host homeostasis, comprises physiological and behavioural changes (Langhans, 2000). 
However, in a severe condition in which the overwhelming infection leads to life-
threatening low blood pressure and decreased tissue perfusion, a medical emergency 
known as septic shock may contribute to organ damage and death. Microbial products such 
as lipopolisaccharides (LPS) from the outer lipid bilayer of gram-negative bacteria cell walls 
are commonly used to model acute illness, leading to the development of sepsis or 
endotoxaemia, depending on the dose of the endotoxin (Borges et al., 2007; 2011; Giusti-
Paiva et al., 2002).  
Hypophagia is part of the acute-phase response to illness. During endotoxaemia, food 
intake is limited and there is an impairment of energy expenditure. Experimental models 
have demonstrated that LPS dramatically reduces food consumption (Gautron et al., 2005; 
Sachot et al., 2004), being this hypophagic effect mainly elicited by the production of 
proinflammatory cytokines (Johnson, 1998; Wise et al., 2006). Consistent with the 
contribution of proinflammatory cytokines to this illness-induced hypophagia are the 
studies showing that their peripheral or central administration restrains eating, and that the 
acute antagonism of their actions attenuates this anorexic response (Asarian & Langhans, 
2010). 
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The systemic administration of LPS triggers the synthesis and release of interleukin (IL)-1β, 
IL-6 and tumor necrosis factor (TNF)-α by monocytes and macrophages. In turn, these 
cytokines can exert local actions as signaling molecules to activate the immune system and 
the HPA axis (Turnbull and Rivier, 1999; Turnbull et al., 1998). Accordingly, it has been 
demonstrated that cytokines induce intense nuclear c-Fos immunoreactivity in CRF 
parvocellular neurons of the PVN (Matsunaga et al., 2000). Endotoxin also increases CRF 
synthesis and secretion, stimulating ACTH release from the pituitary corticotrophs and, 
consequently, the secretion of glucocorticoids from the adrenal cortex (Borges et al., 2007; 
Turnbull & Rivier, 1999). In turn, glucocorticoids inhibit the induction of proinflammatory 
cytokines, mostly by interacting with the intracellular GR, which culminates with the 
activation of NFκB and AP-1 (Jonat et al., 1990; Munoz et al., 1996). After glucocorticoid 
binding to the cytosolic GR, the activated complex is translocated to the cell nucleus, where 
it interacts with the specific transcription factors AP-1 and NF-κB and prevents the 
transcription of targeted genes, in a process called transrepression. Glucocorticoids are able 
to prevent the transcription of many inflammation-associated genes, such as those ones 
encoding cytokines, including interleukins IL-1B, IL-4, IL-5 and IL-8, chemokines, 
arachidonic acid metabolites and adhesion molecules. The immunosuppressant action 
exerted by glucocorticoids may be also evidenced by the increased hypothalamic messenger 
RNA (mRNA) expression of cytokines and IL-1β plasma levels observed in response to LPS 
administration to ADX rats (Goujon et al., 1996).  
Within this context, glucocorticoids appear as crucial hormones involved in the mobilization 
of stored peripheral energy, directing the metabolism to the production of key substrates 
utilized by the liver to sustain gluconeogenesis. Studies performed in rats show that the 
search and consumption of palatable foods are stimulated by corticosterone in a dose-
related fashion (Dallman et al., 2007). Accordingly, these authors have also demonstrated 
that ADX rats exhibit poor weight gain, low fat content and increased sympathetic and HPA 
axis outflow, effects that are, in general, reversed by replacement with corticosterone. The 
removal of the negative feedback exerted by glucocorticoids in ADX animals has been also 
implicated in the increased expression of CRF mRNA in the PVN (Herman & Morrison, 
1996; Rorato et al., 2008). In addition to its essential function in the control of HPA axis 
activity, CRF also has a physiological role in the control of food intake, as evidenced by the 
anorexigenic response induced by central administration of CRF and CRF-related peptides 
to experimental animals (Kalra et al., 1999; Richard et al., 2002), as previously discussed in 
this chapter. Furthermore, the use of a CRF receptor antagonist partially reverses the 
reduction in food intake induced by different stress paradigms (Hotta et al., 1999; Krahn et 
al., 1986). Accordingly, Borges and coworkers (2007) observed that increased CRF mRNA 
expression in the PVN precedes LPS-induced anorexia. Hence, an interchange between 
feeding control and HPA axis activity is conceivable to operate in basal conditions as well as 
following an immune challenge. 
Recently, Saito and Watanabe (2008) have described that dexamethasone treatment 
attenuates the production of multiple proinflammatory cytokines by the brain and liver, 
suggesting a potential preventive effect of glucocorticoids on the LPS-induced hypophagia. 
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Furthermore, Rorato and coworkers (2008) reported that the anorexigenic effect induced by 
LPS is amplified in ADX rats and that the ADX-induced glucocorticoid deficiency promotes 
an increased activation of hypothalamic CRF and POMC neurons. It has been already 
demonstrated that the activation of POMC neurons promotes the release of α-melanocyte 
stimulating hormone (α-MSH), which, in turn, activates melanocortin 4 receptor (MC4R) 
(Cone, 2005). Melanocortin has been also implicated in the LPS-induced hypophagia, since 
the administration of exogenous α-MSH intensified, whereas the antagonism of MC4R 
attenuated the inhibitory effect of LPS on food intake (Fan et al., 1997; Huang et al., 1999). 
Within this context, glucocorticoids appear as negative regulators of melanocortin signaling, 
since ADX was shown not only to reduce AgRP expression in the hypothalamus of wild 
type mice, but also to reverse obese phenotype and restore hypothalamic melanocortin tone 
to control levels in leptin-deficient ob/ob mice (Makimura et al., 2000). 
A growing body of evidence has recently linked obesity to a chronic low-grade 
inflammatory state (Paternain et al., 2011; Trayhurn & Wood, 2005). In fact, inflammation 
may contribute to a range of metabolic disturbances related to obesity, such as diabetes 
mellitus and cardiovascular diseases (Oren et al., 2007). Rats fed with high-fat diet express 
high levels of TNF-α, IL-6 and IL-1β in the hypothalamus, which is consistent with the 
development of an inflammatory process (Milanski et al., 2009). Cani and coworkers (2007) 
have demonstrated that endotoxaemia dysregulates the inflammatory tone and induces 
body weight gain and diabetes in mice, showing that a 4-week high-fat diet induced a two 
to three-fold increase in plasma LPS concentrations. The bacterial endotoxin is normally 
present in the human intestinal tract (Kelly et al., 2012). Accordingly, LPS is detectable in the 
circulation of both healthy and obese individuals, but it may transiently raises following 
energy-rich meals. It has also been shown that the intake of fat-rich diet acts as an inducer of 
chronic stress, elevating basal glucocorticoid levels and enhancing HPA axis responses to 
stress (Tannenbaum et al., 1997), suggesting that glucocorticoids are likely to participate in 
the pathogenesis of metabolic syndrome and obesity (Milagro et al., 2007; Paternain et al., 
2011), even though obese individuals and patients with metabolic syndrome do not 
necessarily show elevated systemic glucocorticoid concentrations (Pereira et al., 2012). 
In face of these findings, efforts are now being turned to clarify the significance of 
glucocorticoids in counteracting the pathophysiology of illness-induced hypophagia. The 
better understanding of these processes may place glucocorticoids as important 
pharmacological targets to deal with obesity and metabolic syndrome, in which 
inflammatory modulators seem to play a key role.  
3. Endocannabinoids as potential intermediates of glucocorticoids actions 
3.1. Endocannabinoids: general aspects 
The pharmacological properties of the plant Cannabis sativa are knwon since ancient times. 
The first cannabinoid receptor (CB1R) was characterized in 1988 and its predominant 
distribution through the CNS initially suggested a relationship with the control of cognitive 
function. However, over the past few years, the number of studies investigating the 
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participation of CB1R in several areas has increased dramatically. Pioneer studies revealed 
that the exogenous administration of “cannabis-like” compounds inhibits the activity of 
diverse neuroendocrine functions (Lomax, 1970; Rettori et al., 1990; Tyrey, 1978). 
Accordingly, it has been demonstrated that the mRNA for the CB1R is expressed in the 
hypothalamus and in the external layer of the median eminence of rodents (Herkenham et 
al., 1991; Wittmann et al., 2007), as well as in both the anterior and intermediate lobes of the 
human pituitary gland (Pagotto et al., 2001). The evidence of the local production of 
endocannabinoids provided by this later group further suggested a role for these substances 
on the direct control of pituitary function.  
In this context, the CB1R has been implicated in most, if not all, the actions of endogenously 
produced cannabinoids in neurotransmission. It has been also demonstrated that 
hippocampal astrocytes functionally express the CB1R and respond with elevations in 
intracellular calcium concentrations to the stimulation by neurotransmitters released locally 
from neuronal sources (Navarrete & Araque, 2008). This evidence suggests that non-
neuronal populations can also contribute to the complexity of the responses elicited by 
endocannabinoids within the CNS. Differently from CB1R, the second cannabinoid receptor 
(CB2R) was identified in immune cells, being predominantly distributed in the peripheral 
organs, but not restricted to them. Most of the actions of the endocannabinoid system are 
mediated by the interaction of endogenous ligands with CB1R or CB2R, although the precise 
actions of orphan receptors, such as GPR55, still remain to be elucidated. 
The identification of this receptor system, as well as the description of well-known effects 
induced by the consumption or administration of “cannabis-like” substances in humans, 
suggested the existence of endogenous ligands to be discovered. Anandamide (AEA) was 
the first one, followed by 2-araquidonoilglicerol (2-AG), the main endocannabinoids studied 
so far. AEA binds to CB1R with high affinity and regulates the signaling cascade as a partial 
agonist (Bouaboula et al., 1995). On the other hand, 2-AG, besides being the most abundant 
endocannabinoid produced by the CNS, has a lower affinity for CB1R when compared to 
AEA but stimulates the intracellular signaling pathway as a full agonist (Mechoulam et al., 
1995). Both AEA and 2-AG are synthesized on demand from membrane phospholipids after 
the activation of membrane-associated glucocorticoid receptors. AEA and 2-AG are also 
metabolized by independent enzymatic pathways (Freund et al., 2003). Indeed, AEA acts as 
a very promiscuous ligand, since it can also bind to type 1 vanilloid (TRPV1) receptors with 
high affinity (Tóth et al., 2005). Accordingly, some of the effects induced by AEA cannot be 
mimicked by the administration of the synthetic cannabinoid agonist WIN55,212-2 (Al-
Hayani et al., 2001) and the well-known AEA-induced antinociception is still preserved in 
experimental animals lacking the CB1R gene (Di Marzo et al., 2000). 
3.2. Endocannabinoids and the ingestive behaviour 
3.2.1. Food intake 
It has been demonstrated that glucocorticoids increase endocannabinoid levels in 
hypothalamic PVN slices, supporting the hypothesis that at least part of the effects induced 
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by glucocorticoids on food intake are mediated by these lipid-derived mediators (Malcher-
Lopes et al., 2006). In this study, Malcher-Lopes and colleagues also demonstrated that the 
glucocorticoid-mediated activation of a membrane receptor coupled to a Gαs–cAMP–PKA 
signaling cascade leads to an increase in endocannabinoid synthesis. Accordingly, increased 
hypothalamic levels of endocannabinoids have been also observed in vivo following 
glucocorticoid treatment (Hill et al., 2010).  
Both endocannabinoids and glucocorticoids injected into hypothalamic areas induce similar 
effects on eating behaviour, increasing food consumption (Jamshidi & Taylor, 2001; Tempel 
et al., 1992). The synthesis of endocannabinoids in the hypothalamus and the expression of 
both endocannabinoids and glucocorticoid receptors in synapses and in hypothalamic 
neurons that synthesize peptides with a key role in food consumption reinforce this 
assumption (Castelli et al., 2007; Cota et al., 2003; Deli et al. 2009; Di Marzo et al., 2001; 
Malcher-Lopes et al., 2006). In fact, the neuropeptides CRF, OT and TRH, which have well 
described anorexigenic properties (Arletti et al., 1989, 1990; Morley et al., 1983; Steward et 
al., 2003), appear as potential targets for endocannabinoid-mediated actions induced by 
glucocorticoids. Therefore, the glucocorticoid-mediated blockade of excitatory glutamatergic 
synapses induced by endocannabinoids via CB1R has been already described in CRF, OT 
and TRH hypothalamic neurons (Di et al., 2003). 
Although feeding is one of the main synchronizers of the HPA axis activity and both the 
endocannabinoid system and glucocorticoids seem to drive the organism into an increased 
ingestive behaviour under physiological conditions, several studies reported both 
stimulatory and inhibitory roles for endocannabinoids in the control of stress responses. In 
the experiments conducted by Patel and co-workers (2004), mice pretreated with a CB1R 
antagonist exhibited a robust increase in the restraint-induced glucocorticoid release and c-
Fos immunolabeling in the PVN. In addition, the administration of a CB1R agonist, an 
inhibitor of endocannabinoid transport or a FAAH inhibitor attenuated the restraint-
induced increase in glucocorticoid secretion. Although these authors hypothesized that the 
activation of endogenous CB1R may negatively modulate the HPA axis activity, they also 
demonstrated that the hypothalamic contents of 2-AG were, respectively, decreased and 
enhanced after acute and sustained stress. This finding is not consistent with an 
endocannabinoid-mediated inhibition of the HPA axis activity, but rather indicates that 
glucocorticoids may centrally inhibit the production of endocannabinoids. Similar results 
were obtained by Borges and colleagues (2011), who reported decreased hypothalamic 2-AG 
contents after acute LPS administration. Additionally, increased CRF mRNA expression, 
glucocorticoid plasma concentrations and hypophagia were found by this group in 
experimental animals submitted to a single LPS injection, being all these responses 
completely restored to basal levels following repeated LPS administration. 
Conversely, an increase in hypothalamic 2-AG levels after acute restraint stress has also 
been recently reported (Evanson et al., 2010). According to these findings, these authors 
proposed that the CB1R-mediated signaling is required for glucocorticoid negative 
feedback, but not for the initial HPA axis response to restraint. In addition, a down-
regulation of CB1R and an impaired glucocorticoid-mediated inhibition of excitatory inputs 
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to parvocellular PVN neurons were observed in hypothalamic slices from rats submitted to 
repeated immobilization stress (Wamsteeker et al., 2010). Interestingly, application of a 
CB1R agonist to the bath did not suppress the excitatory inputs onto PVN neurons, 
suggesting that the CB1R-mediated signaling may be disrupted after prolonged exposure to 
stress. It has been recently reported by our group that the pharmacological blockade of the 
CB1R-mediated signaling during LPS-induced endotoxaemia produces a remarkable 
increase in the activation of CRF neurons in the parvocellular subdivision of the PVN, which 
is associated with a pronounced hypophagia (Rorato et al., 2011). Although further studies 
are needed to clarify the precise actions of endocannabinoids on stress responses, the 
majority of studies suggest that the endocannabinoid system may mediate the fast negative 
feedback exerted by glucocorticoids at both hypothalamic and pituitary levels, avoiding the 
overloading of this system and making it continuously responsive to other potential 
challenges.  
It has been also observed that the peripheral nutrition-related hormone leptin reverses the 
increases in PVN endocannabinoid levels induced by glucocorticoids, indicating a central 
crosstalk between glucocorticoids and this satiety signal (Malcher-Lopes et al., 2006). In fact, 
Obese Zucker rats, which do not express leptin receptors, are hyperphagic and exhibit 
elevated glucocorticoid plasma levels (Ahima, 2000; Freedman et al., 1985) and increased 
hypothalamic levels of endocannabinoids (Di Marzo et al., 2001; Kirkham et al., 2002). 
Within this context, the study of the CB1R-mediated signaling has a great clinical relevance 
and expectation, since obesity is emerging as a very concerning heath problem worldwide, 
either considered alone or in association with other chronic degenerative diseases. 
Accordingly, an increasing number of recent studies have focused on the glucocorticoid-
related effects mediated by CB1R, such as the central control of food consumption (Di 
Marzo et al., 2001) and satiety (Matias & Di Marzo, 2007), as well as the peripheral control of 
adiposity, a predictor of several chronic metabolic disorders (Westerink & Visseren, 2011). 
Although the endocannabinoid system has been implicated in several physiological and 
pathological functions related to the control of food intake and body weight by 
glucocorticoids (Ameri, 1999; Bisogno et al., 2005; Di Marzo & Matias, 2005; Marco et al., 
2011), it has been also demonstrated that these lipid-derived mediators can act 
independently of the glucocorticoid-mediated signalling (Jamshidi & Taylor, 2001; Kirkham 
& Williams, 2001; Williams & Kirkham, 1999; Williams et al. 1998). Most of these effects are 
also mediated by the activation of the CB1R, since the administration of the CB1R antagonist 
rimonabant reverses the cannabinoid-induced increase in food intake (Jamshidi & Taylor, 
2001; Williams & Kirkham, 2002). Consistent with the CB1R-mediated orexigenic effects of 
endocannabinoids, transgenic mice that lack this receptor subtype or experimental animals 
treated with the CB1R antagonist exhibit decreased food consumption (Colombo et al. 1998; 
Di Marzo et al. 2001; Pertwee, 2005). 
This rimonabant-induced decrease in food intake is, at least in part, mediated by changes in 
endocannabinoid signalling within the hypothalamus (Cota et al., 2003; Mailleux & 
Vanderhaeghen, 1992; Marsicano & Lutz, 1999). It has been already reported that the CB1R 
is co-expressed with several anorexigenic peptides such as CART and CRF (Asakawa et al., 
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2001; Cota et al., 2003; Füzesi et al., 2008; Morley et al., 1983; Vrang et al., 2000). Accordingly, 
CB1R knockout mice exhibit increased CRF mRNA expression in the PVN (Cota et al., 2003). 
It has been also demonstrated that acute rimonabant treatment induces an increase in the co-
localization of c-Fos with CART in the PVN and ARC and with POMC in the ARC, as well 
as promotes a decrease in both the protein and the mRNA for NPY in the ARC (Verty et al., 
2009a). Conversely, no changes in NPY or POMC mRNA expression were found in the ARC 
of lean rats treated with rimonabant (Doyon et al., 2006), although the administration of 
AM251, a selective CB1R antagonist, blocked NPY release from hypothalamic explants 
(Gamber et al., 2005) and the POMC-expressing neurons were shown to release 
endocannabinoids under basal conditions (Hentges et al. 2005).  
In the brainstem, the CB1R and the enzyme that metabolizes AEA, fatty acid amide 
hydrolase (FAAH), are expressed in the dorsal vagal complex, which includes the NTS (Van 
Sickle et al., 2001). In addition, peripheral vagal afferents expressing CB1R and the local 
production of AEA by the gastrointestinal tract are important food-stimulated signals 
involved with the control of food intake and meal size (Burdyga et al., 2004, 2010; Gómez et 
al., 2002; Jelsing et al., 2009a,b). Accordingly, our group has recently demonstrated that the 
previous CB1R blockade potentiates LPS-induced increase in the number of TH-expressing 
neurons of the NTS co-localizing c-Fos, suggesting that endocannabinoids may modulate 
satiety during an immune challenge. 
Endocannabinoids can also modulate the hedonistic component of food intake. It has been 
demonstrated that the cannabinoid agonist THC increases the motivation to eat palatable 
food (Gallate et al., 1999), whereas the CB1R antagonism reduces this response (Simiand et 
al., 1998). Changes in content of endocannabinoids in the limbic forebrain regions were 
shown to be correlated with the nutritional status in experimental animals (Kirkham et al., 
2002). Furthermore, the expression of the CB1R in the accumbens shell nucleus (NAcS), a 
key structure involved with motivation and reward, reinforce this hypothesis (Di Marzo et 
al., 2009). It is already known that dopamine release within NAcS is associated with 
rewarding associated with the addictive properties of abuse drugs (Volkow et al., 2007). 
Interestingly, it was observed that the administration of a CB1R antagonist attenuates the 
increases in dopamine release within this nucleus induced by a novel high palatable food 
(Melis et al., 2007), indicating that endocannabinoids may account for the integrated control 
of feeding-associated motivated behaviour. 
In addition to their central effects on the control of hunger and satiety, the endocannabinoid 
signalling has been also implicated in the peripheral control of body weight through 
changes in energy storage and expenditure (Silvestri et al., 2011). Interestingly, SV40 
immortalised murine white and brown adipocytes treated with rimonabant show increased 
uncoupling protein 1 (UCP1) expression (Perwitz et al., 2010), which is associated with the 
preferential production of heat. Furthermore, Quarta and colleagues (2010) have 
demonstrated that mice lacking CB1R exhibit a lean phenotype due to an increased lipid 
oxidation and thermogenesis. Accordingly, prolonged rimonabant administration was 
shown to increase lipolysis and decrease fat storage in white adipose tissue of mice with 
diet-induced obesity (Jbilo et al., 2005). A recent report from Verty and co-workers (2009b) 
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has proposed that this response may be mediated by the autonomic nervous system, since 
the denervation of the sympathetic afferents blocked the effect of rimonabant on body 
weight.  
3.2.2. Fluid intake 
Although the endocannabinoid system has a great impact on the regulation of energy 
homeostasis, its participation in the control of fluid intake remains elusive. A pioneer study 
has demonstrated that the exogenous administration of compounds derived from the plant 
Cannabis sativa inhibits water intake (Sofia & Knobloch, 1976). On the other hand, the CB1R 
blockade significantly reduced water intake in the experiments conducted by Gardner & 
Mallet (2006). Recent studies have also reported that endocannabinoids increase the 
preference for palatable solutions such as sucrose (Higgs et al., 2003; Jarrett et al., 2005), 
without altering the drinking of salty solutions or distilled water induced by fluid 
deprivation (Yoshida et al., 2010). However, these conflicting results could be explained, at 
least in part, by the parallel effects of the endocannabinoid system in the control of 
locomotor activity, which could directly interfere with the search for eating and drinking. 
The specific appetite for sodium and water is a very important adaptative response 
recruited to restore body fluid homeostasis. However, the excessive intake of sodium in 
industrialized food has a great impact in modern society, since it may be directly associated 
with the impairment of cardiovascular and renal functions. The neuropeptide OT appears as 
an important negative modulator of salt appetite in rats, being particularly relevant in 
osmolality- but not in the sodium-dependent inhibition of this ingestive behaviour 
(Blackburn et al., 1993). Furthermore, OT has been implicated in the central inhibition of 
water intake induced by water deprivation, hypertonic saline administration and 
angiotensin II injection (Arletti et al., 1990). More recently, studies developed by Verty and 
co-workers (2004) revealed that these effects of OT on water intake may be partially 
mediated by CB1R. 
An empirical and very interesting observation is that animals that undergo periods of 
restricted or no access to water also reduce their food consumption, being this anorexic state 
as long as the water restriction persists. It is believed that this reduction in food intake is a 
compensatory mechanism, since a slight change in the osmolality of the gastrointestinal tract 
circulation may be detected after the beginning of the digestive process. This would 
contribute to a further increase in the already enhanced plasma osmolality, constituting a 
very life-threatening situation. Although some studies suggest the participation of central 
increases in CRF in this anorexic response induced by chronic exposure to osmotic stress 
(Koob et al., 1993; Krahn et al., 1986; Morley, 1987), it is clear that this decreased food intake 
occurs earlier than the activation of the HPA axis. Accordingly, no changes in c-Fos/CRF 
immunoreactivity or CRF mRNA expression were found in the hypothalamus of animals 
submitted to 24 hours (h) water restriction, despite the fact that the anorexigenic response, 
as well as the decrease in body weight, had already been observed after this short period 
(Ruginsk et al., 2011).  
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Furthermore, it has been also demonstrated by Ruginsk and coworkers (2011) that the 
number of CART neurons activated to produce c-Fos is increased in the hypothalamus of 
24h water-deprived rats. Since CART is a well-known anorexigenic peptide, these results 
suggest a possible intersection between pathways controlling food and fluid intake. These 
results further propose the existence of an osmolality-related mechanism in this interface, 
since the immunoreactivity for c-Fos/CART and the CART mRNA expression in the PVN 
and supraoptic (SON) nuclei of the hypothalamus were increased after hypertonic but not 
isotonic extracellular volume expansion (Ruginsk et al., 2011). 
4. Endocannabinoids and the control of hydromineral homeostasis 
The magnocellular neurosecretory system consists of a group of neurons whose cell bodies 
are located at the PVN and SON in the hypothalamus and whose terminals, located at the 
neurohypophysis, release vasopressin (AVP) and OT in response to depolarization. Both 
neuropeptides act in the kidneys to control the excretion of water and electrolytes. AVP is 
mostly known for its antidiuretic and vasoconstrictor effects, while OT, together with atrial 
natriuretic peptide (ANP) produced by the heart, are the two major circulating hormones 
stimulating natriuresis and diuresis.  
Immunohistochemical studies have revealed that GR and MR are co-localized in the 
parvocellular subdivision of the PVN, but not in magnocellular neurons, which 
predominantly express MR (Han et al., 2005). Accordingly, it has been demonstrated that 
high doses of dexamethasone can inhibit OT but not AVP secretion in response to 
hypertonic extracellular volume expansion (Durlo et al., 2004; Ruginsk et al., 2007) and 
central cholinergic, angiotensinergic and osmotic stimulation (Lauand et al., 2007). These 
effects were also correlated with immunohistochemical data, showing that the 
magnocellular neurons of the PVN and SON are inhibited by dexamethasone administration 
(Ruginsk et al., 2007).  
More recently, the activation of membrane-associated glucocorticoid receptors has been 
proposed using hypothalamic slice preparations. It has been demonstrated that 
glucocorticoids could activate at least two divergent intracellular pathways mediated by Gαs 
and Gβγ subunits. The local production of endocannabinoids and NO would then result in 
two synapse-specific mechanisms, respectively: 1) suppression of excitatory (glutamatergic) 
synaptic inputs and 2) facilitation of inhibitory (GABAergic) synaptic inputs to the 
hypothalamic magnocellular neurosecretory system (Di et al., 2003, 2005, 2009), 
consequently decreasing AVP and OT release from neurohypophyseal terminals. These 
actions on glutamatergic neurotransmission would be dependent on the activation of the 
CB1R, located mainly at presynaptic terminals. Accordingly, it has been recently 
demonstrated that the administration of rimonabant potentiates AVP and OT release as well 
as the number of c-Fos/AVP and c-Fos/OT double immunoreactive neurons in the PVN and 
SON of experimental animals submitted to hypertonic extracellular volume expansion 
(Ruginsk et al., 2010). Furthermore, the participation of the CB1R in the glucocorticoid-
induced inhibition of the magnocellular neurosecretory system was clearly demonstrated by 
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the same group, since the previous administration of rimonabant reversed the inhibitory 
effects of dexamethasone on hormone release (Ruginsk et al., 2012). 
Although many brain regions seem to share similar cellular mechanisms triggered by 
endocannabinoids, their central actions can vary widely within the CNS. Several studies 
suggest that the endocannabinoid system can mediate not only the central effects of 
glucocorticoids but also independently modulate the excitability of postsynaptic terminals 
after the dendritic-mediated release of neuropeptides like OT (Hirasawa et al., 2004; 
McDonald et al., 2008; Oliet et al., 2007). This mechanism is likely to be implicated in the 
intra-hypothalamic feedback on hormone release and neuroplasticity (de Kock et al., 2003). 
The CB1R is also expressed in the NTS (Tsou et al., 1998), a key structure involved in the 
control of cardiovascular function that projects to the hypothalamus. Accordingly, the 
central administration of CB1R agonists was shown to reduce blood pressure and heart rate 
(Lake et al., 1997), while the microinjection of a CB1R antagonist into the NTS resulted in 
prolonged hypotension after activation of the baroreflex in experimental animals 
(Rademacher et al., 2003).  
Besides participating in the central control of cardiovascular function, recent reports also 
suggest a role for peripherally-synthesized cannabinoids in the control of blood pressure. 
This hypothesis is supported by the evidence that the CB1R is expressed by human, rat and 
guinea-pig atria (Bonz et al., 2003; Kurz et al., 2008; Sterin-Borda et al., 2005). Within the 
heart, the activation of the CB1R induces a negative inotropic response on muscular fibers, 
thus reducing blood pressure. This is of particular interest for the study of the integrated 
cardiovascular and neuroendocrine responses to an increase in the circulating volume, since 
the distension of cardiac chambers (especially the right atria) in response to such 
experimental condition is the main stimulus for ANP secretion. Indeed, a role for the CB1R 
in ANP release has been recently proposed (Ruginsk et al., 2012), although further studies 
are needed to support this hypothesis. 
5. Conclusions and perspectives 
Besides the well-known effects on energy homeostasis and metabolism, the ability of 
glucocorticoids to suppress inflammatory responses has been extensively explored in 
therapeutics during the last fifty years. However, the clinical potential of glucocorticoids has 
not been fully achieved because of the severe dose-limiting side effects as well as the 
development of glucocorticoid resistance. More recently, a lot of expectation was put on 
characterization of non-steroidal dissociated GR agonists and modulators, which try to 
uncouple the desired and adverse effects of glucocorticoid administration based on the type 
of GR interaction with the DNA (transactivation and trasnrepression). However, the 
difficulty to transpose the effects to in vivo set-ups and their still unproved long-term safety 
have limited the use of these drugs in clinical practice so far.  
In this context, different approaches to improve the benefit/risk ratio of glucocorticoids also 
include the development of drugs that selectively target the activation of membrane-
associated GRs and its downstream nongenomic events, without evoking adverse effects, 
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primarily attributed to the activation of genomic pathways. Therefore, the study of the 
nongenomic actions of glucocorticoids has introduced a novel player in the complexity of 
the circuitries regulated by the HPA axis and the integrated control of homeostasis. The 
endocannabinoid system appears as an important mediator of both central and peripheral 
effects of glucocorticoids, constituting a possible target by which several aspects of stress-
mediated responses and energy acquisition/expenditure could be manipulated under 
diverse physiological and pathological conditions.  
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